journal article·2026-03Open access

Programmable Pentamolecular Cross‐Scale Imaging Reveals the Multiplicative Synergistic Effect of High‐Fat / High‐Salt Diet on Atherosclerosis

Jin Li, Na Zhao, Mengmeng Lu, Ruize Zhao, Wei Zhang, Ping Li, Yue Tang, Wen Zhang, Hui Wang, Bo Tang

Advanced Science· Volume 13· Issue 13

Abstract

ABSTRACT Atherosclerosis, as a lipid‐driven chronic inflammatory disease, exhibits close correlation between its early formation and dietary habits, yet lacks closely associated molecular demonstration mechanisms. To address this, we constructed nanosenors for H 2 O 2 , HClO, GSH, and AA, achieving cross‐scale fluorescence imaging at cellular, tissue, and in vivo levels for five spectrally distinguishable molecular species through programmed combination of three probe types: oxidative (H 2 O 2 , HClO), reductive (GSH, AA), and protein phosphorylation. Using rat models fed with high‐fat, high‐salt, or combined diets, our cross‐scale imaging of oxidative/reductive substances and phosphorylated proteins revealed that both high‐fat and high‐salt diets independently induce redox imbalance in vasculature and organs while significantly elevating protein phosphorylation levels. Notably, the combined high‐fat/high‐salt group demonstrated oxidative stress and protein phosphorylation levels exceeding the additive effects of individual diets (“1+1>2” synergy), unveiling their cooperative acceleration of atherosclerotic progression. This finding provides crucial experimental evidence for understanding the multifactorial synergistic mechanisms whereby lifestyle factors exacerbate oxidative stress and protein phosphorylation in atherosclerosis pathogenesis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Molecular Sensors and Ion Detection · Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry Chemical Engineering and Materials Science Key Laboratory of Molecular and Nano Probes Collaborative Innovation Center of Functionalized Probes For Chemical Imaging in Universities of Shandong Institutes of Biomedical Sciences Ministry of Education Shandong Normal University Jinan Shandong P. R. China

Department of Emergency Medicine Shandong Provincial Clinical Research Center For Emergency and Critical Care Medicine Qilu Hospital of Shandong University Jinan Shandong P. R. China

Laoshan Laboratory Aoshanwei Jimo Qingdao Shandong P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province

References (43)

Show source-provided references
1. 10.1016/j.cell.2022.04.00410.1016/j.cell.2022.04.004 ↗
2. Distinct Inflammatory Pathways Shape Atherosclerosis in Different Vascular Beds
3. 10.1093/eurheartj/ehae93310.1093/eurheartj/ehae933 ↗
4. 10.1038/s41569-024-01110-110.1038/s41569-024-01110-1 ↗
5. 10.1038/s41590-025-02132-810.1038/s41590-025-02132-8 ↗
6. 10.1038/s41569-024-01007-z10.1038/s41569-024-01007-z ↗
7. 10.1161/CIRCULATIONAHA.117.03048410.1161/CIRCULATIONAHA.117.030484 ↗
8. 10.1093/eurheartj/ehad30410.1093/eurheartj/ehad304 ↗
9. 10.1016/j.immuni.2025.01.00310.1016/j.immuni.2025.01.003 ↗
10. 10.1038/s41392-024-02095-610.1038/s41392-024-02095-6 ↗
11. 10.1038/s41580-024-00730-210.1038/s41580-024-00730-2 ↗
12. 10.1016/j.cmet.2015.06.00610.1016/j.cmet.2015.06.006 ↗
13. 10.1038/s41467-017-02746-z10.1038/s41467-017-02746-z ↗
14. 10.1152/physrev.00033.201610.1152/physrev.00033.2016 ↗
15. 10.1038/nrmicro.2017.2610.1038/nrmicro.2017.26 ↗
16. 10.1016/j.jacc.2018.02.08510.1016/j.jacc.2018.02.085 ↗
17. 10.1016/j.jacc.2020.04.08210.1016/j.jacc.2020.04.082 ↗
18. 10.1093/eurheartj/ehad26910.1093/eurheartj/ehad269 ↗
19. 10.1093/eurheartj/ehaa20910.1093/eurheartj/ehaa209 ↗
20. 10.1038/s41591-024-03165-610.1038/s41591-024-03165-6 ↗
21. 10.1038/s41392-024-01771-x10.1038/s41392-024-01771-x ↗
22. 10.1093/ehjci/ehaa946.273710.1093/ehjci/ehaa946.2737 ↗
23. 10.1016/j.jacc.2020.11.05910.1016/j.jacc.2020.11.059 ↗
24. 10.1161/CIRCULATIONAHA.120.04646410.1161/CIRCULATIONAHA.120.046464 ↗
25. 10.1016/j.molcel.2021.08.01810.1016/j.molcel.2021.08.018 ↗
26. 10.1021/acs.chemrev.7b0069810.1021/acs.chemrev.7b00698 ↗
27. 10.1016/j.redox.2018.11.00510.1016/j.redox.2018.11.005 ↗
28. 10.1016/j.immuni.2016.06.02010.1016/j.immuni.2016.06.020 ↗
29. 10.1002/anie.20230216110.1002/anie.202302161 ↗
30. 10.1002/adma.20230700810.1002/adma.202307008 ↗
31. 10.1002/adfm.20250388510.1002/adfm.202503885 ↗
32. 10.1021/jacs.4c0117310.1021/jacs.4c01173 ↗
33. 10.1021/acs.analchem.1c0169010.1021/acs.analchem.1c01690 ↗
34. 10.1016/j.snb.2019.12673110.1016/j.snb.2019.126731 ↗
35. 10.1021/acs.analchem.0c0092510.1021/acs.analchem.0c00925 ↗
36. 10.1016/j.aca.2022.34041410.1016/j.aca.2022.340414 ↗
37. 10.1021/acs.analchem.9b0487810.1021/acs.analchem.9b04878 ↗
38. 10.1038/s41569-023-00883-110.1038/s41569-023-00883-1 ↗
39. 10.1016/j.redox.2021.10197910.1016/j.redox.2021.101979 ↗
40. 10.1016/j.biopha.2018.03.10710.1016/j.biopha.2018.03.107 ↗
41. 10.1002/anie.20221517810.1002/anie.202215178 ↗
42. 10.1021/cr200410310.1021/cr2004103 ↗
43. 10.1039/C8SC02638F10.1039/C8SC02638F ↗